Tag #Immunotherapy

Showing 73 to 79 of 79 results

pda.kp.ru

🌐 85% Global Worthiness

Dec 17, 19:11

Russia Begins Human Trials of Personalized Cancer Vaccine

Russia is conducting human clinical trials for "EnteroMix," a personalized cancer vaccine using oncolytic viruses, targeting patients with solid tumors who have exhausted standard treatment options, offering a potentially revolutionary approach to cancer treatment.

Russia Begins Human Trials of Personalized Cancer Vaccine

Russia is conducting human clinical trials for "EnteroMix," a personalized cancer vaccine using oncolytic viruses, targeting patients with solid tumors who have exhausted standard treatment options, offering a potentially revolutionary approach to cancer treatment.

Progress

44% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the significance of Russia's clinical trials for the "EnteroMix" cancer vaccine?

Russia is developing two cancer vaccines, one of which, "EnteroMix," is undergoing human clinical trials. Unlike preventative vaccines, this vaccine stimulates the immune system to fight existing cancer by using a patient's own tumor cells to create a personalized vaccine.

dailymail.co.uk

🌐 85% Global Worthiness

Dec 11, 22:09

GLP-1 Weight Loss Drugs May Reduce Breast Cancer Treatment Efficacy

A study of hundreds of women with triple-negative breast cancer found that those taking GLP-1 weight-loss drugs like Ozempic and Wegovy had significantly lower remission rates (28% vs 63%) after treatment, suggesting interference with chemotherapy and immunotherapy effectiveness.

GLP-1 Weight Loss Drugs May Reduce Breast Cancer Treatment Efficacy

A study of hundreds of women with triple-negative breast cancer found that those taking GLP-1 weight-loss drugs like Ozempic and Wegovy had significantly lower remission rates (28% vs 63%) after treatment, suggesting interference with chemotherapy and immunotherapy effectiveness.

Progress

52% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the impact of GLP-1 weight loss drugs on the efficacy of breast cancer treatments?

A new study shows that GLP-1 weight loss drugs, like Ozempic and Wegovy, may negatively impact the effectiveness of breast cancer treatments. In a study of hundreds of women with triple-negative breast cancer, only 28% of those taking GLP-1 drugs achieved complete cancer remission after treatment, compared to 63% of those not taking the drugs. This suggests a potential interference with chemotherapy and immunotherapy.

napoli.repubblica.it

🌐 85% Global Worthiness

Dec 4, 19:09

Oncolytic Virus Immunotherapy Shows Promise for Advanced Melanoma

In a phase 2 clinical trial, combining the oncolytic virus immunotherapy RP1 with nivolumab resulted in a 30% overall response rate and 15% complete response rate in 140 patients with advanced melanoma unresponsive to prior immunotherapy, leading to FDA Breakthrough Therapy designation.

Oncolytic Virus Immunotherapy Shows Promise for Advanced Melanoma

In a phase 2 clinical trial, combining the oncolytic virus immunotherapy RP1 with nivolumab resulted in a 30% overall response rate and 15% complete response rate in 140 patients with advanced melanoma unresponsive to prior immunotherapy, leading to FDA Breakthrough Therapy designation.

Progress

48% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the mechanism of action of RP1, and what are its immediate impacts on advanced melanoma patients?

A genetically modified herpes simplex virus injected into melanoma eliminates cancer cells directly and indirectly by releasing molecules that stimulate the immune system. This mechanism is the basis of RP1, a new oncolytic virus immunotherapy. When combined with nivolumab, it shows promise for a third of patients with advanced melanoma unresponsive to standard immunotherapy.

repubblica.it

🌐 % Global Worthiness

Nov 5, 13:30

Omalizumab Shows Promise in Treating Childhood Food Allergies

A 10-year study shows the monoclonal antibody Omalizumab significantly improves food tolerance in children with food allergies, offering a potential new treatment avenue.

Omalizumab Shows Promise in Treating Childhood Food Allergies

A 10-year study shows the monoclonal antibody Omalizumab significantly improves food tolerance in children with food allergies, offering a potential new treatment avenue.

Progress

0% Bias Score

ShareSaveArticle

12345678910

Previous 1 of 10 Next

How does Omalizumab work to alleviate food allergy symptoms?

The drug works by binding to free IgE antibodies, preventing allergic reactions. It's not a cure and requires regular injections, but it significantly raises the threshold for allergic reactions.

dailymail.co.uk

🌐 85% Global Worthiness

Dec 17, 01:10

Russia Announces Free Personalized Cancer Vaccine for 2025 Rollout

Russia's health ministry announced a free, personalized cancer vaccine for patients, launching in early 2025, addressing the nation's rising cancer rates exceeding 635,000 cases in 2022, using RNA technology similar to Western approaches.

Russia Announces Free Personalized Cancer Vaccine for 2025 Rollout

Russia's health ministry announced a free, personalized cancer vaccine for patients, launching in early 2025, addressing the nation's rising cancer rates exceeding 635,000 cases in 2022, using RNA technology similar to Western approaches.

Progress

32% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the immediate impact of Russia's announcement of a free, personalized cancer vaccine?

Russia's health ministry announced a free, personalized cancer vaccine launching in early 2025. The vaccine, designed for cancer patients, uses RNA from a patient's tumor to trigger an immune response against cancer cells. Details on which cancers it treats and its effectiveness remain undisclosed.

bari.repubblica.it

🌐 90% Global Worthiness

Dec 9, 19:09

World-First Personalized mRNA Cancer Vaccine Shows Promise in Treating Urinary Tract Cancer

A 75-year-old woman at Bari's Policlinico hospital became the first globally to receive a personalized mRNA cancer vaccine (cevumeran) alongside nivolumab immunotherapy after surgery for high-risk urinary tract cancer; this innovative treatment is designed to address specific tumor mutations, offeri...

World-First Personalized mRNA Cancer Vaccine Shows Promise in Treating Urinary Tract Cancer

A 75-year-old woman at Bari's Policlinico hospital became the first globally to receive a personalized mRNA cancer vaccine (cevumeran) alongside nivolumab immunotherapy after surgery for high-risk urinary tract cancer; this innovative treatment is designed to address specific tumor mutations, offeri...

Progress

56% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the significance of this world-first treatment for urinary tract cancer at Bari's Policlinico?

At Bari's Policlinico hospital, a 75-year-old woman with high-risk urinary tract cancer received a world-first treatment: a personalized mRNA vaccine (cevumeran) combined with nivolumab immunotherapy following surgery. The mRNA vaccine targets specific tumor mutations, boosting the immune system's attack on cancer cells. This innovative approach offers hope beyond conventional chemotherapy, which has limited efficacy and high toxicity.

elmundo.es

🌐 75% Global Worthiness

Nov 18, 16:23

New CAR-T Therapy Shows Promise Against HER2-Positive Cancers

Spanish researchers develop a promising new CAR-T therapy for HER2-driven cancers showing complete and lasting antitumoral response in preclinical trials.

New CAR-T Therapy Shows Promise Against HER2-Positive Cancers

Spanish researchers develop a promising new CAR-T therapy for HER2-driven cancers showing complete and lasting antitumoral response in preclinical trials.

Progress

24% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the next steps planned for this research?

This new CAR-T therapy is a significant advancement in cancer treatment, particularly for HER2-positive tumors. The double-attack strategy addresses the limitations of previous CAR-T therapies against solid tumors, offering hope for a more effective treatment.

Showing 73 to 79 of 79 results